Literature DB >> 2892003

Treatment of lower respiratory infections.

J T Macfarlane1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2892003     DOI: 10.1016/s0140-6736(87)91140-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  The next generation: fluoroquinolones in the management of acute lower respiratory infection in adults.

Authors:  P J Moss; R G Finch
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 2.  Systemic antibiotic treatment of nosocomial pneumonia.

Authors:  K E Unertl; F P Lenhart; H Forst; K Peter
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 3.  Cefpodoxime proxetil in the treatment of lower respiratory tract infections.

Authors:  A M Geddes
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Outbreak of Pneumococcal Pneumonia among Military Recruits.

Authors:  A Banerjee; A T Kalghatgi; G S Saiprasad; A Nagendra; B N Panda; S K Dham; A Mahen; K D Menon; M A Khan
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia.

Authors:  Gregory W Ruhnke; Marcelo Coca-Perraillon; Barrett T Kitch; David M Cutler
Journal:  Am J Med       Date:  2011-02       Impact factor: 4.965

Review 6.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

7.  Pharmacokinetics of a new oral formulation of amoxicillin.

Authors:  M H Prevot; F Jehl; B Rouveix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.569

Review 8.  The epidemiology of infections in intensive care units.

Authors:  A M Emmerson
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

9.  In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.

Authors:  P Moine; E Vallée; E Azoulay-Dupuis; P Bourget; J P Bédos; J Bauchet; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibiotic.

Authors:  S Tamura; S Miyazaki; K Tateda; A Ohno; Y Ishii; T Matsumoto; N Furuya; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.